Karyopharm Therapeutics Inc. - Common Stock (KPTI)
0.0174
+0.00 (0.00%)
NASDAQ · Last Trade: Nov 11th, 10:19 AM EST
After-Hours Stock Movers: KPTI Rises 140%, STAK Falls 51.5% After US Closechartmill.com
Via Chartmill · November 10, 2026
Today's US Session Top Gainers and Decliners: PEPG, OPENZ and TTEC Rise; IHRT, BMGL and MVST Fallchartmill.com
Via Chartmill · November 10, 2026
Top US Market Movers: Today's Session Gainers and Loserschartmill.com
Via Chartmill · November 10, 2026
US Gap-Up and Gap-Down Stocks: Nov. 10, 2026 Sessionchartmill.com
Via Chartmill · November 10, 2026
Most Active US Stocks: Nov. 6, 2026chartmill.com
Via Chartmill · November 6, 2026
Premarket Movers Nov. 10, 2026: Gainers and Loserschartmill.com
Via Chartmill · November 10, 2026
Nov. 9 After-Hours Movers: Gainers and Loserschartmill.com
Via Chartmill · November 9, 2026
US Session Top Movers: FISN, XHLD, TLS Lead Gainers; ZURA, SOC, PLCE Lead Loserschartmill.com
Via Chartmill · November 9, 2026
Top Movers Today: MF Gains 89.56%, ZURA Falls 72.98%chartmill.com
Via Chartmill · November 9, 2026
After-Hours Market Movers: Gainers and Decliners From Today's U.S. Sessionchartmill.com
Via Chartmill · November 6, 2026
Premarket Movers: Gainers and Decliners on Nov. 5, 2026chartmill.com
Via Chartmill · November 5, 2026
Premarket Movers Nov. 2, 2026: Gainers and Loserschartmill.com
Via Chartmill · November 2, 2026
Top US Stock Movers in Today's Sessionchartmill.com
Via Chartmill · October 28, 2026
Let's have a look at the top gainers and losers in the middle of the day of today's session.chartmill.com
Via Chartmill · September 11, 2026
Traders are paying attention to the gapping stocks in Friday's session.chartmill.com
Via Chartmill · September 11, 2026
Which stocks are moving before the opening bell on Friday?chartmill.com
Via Chartmill · September 11, 2026
Karyopharm (KPTI) Q2 2026 Earnings Call Transcriptfool.com
Biotech pivots to hematology after endometrial cancer setback, faces debt deadline.
Via The Motley Fool · August 20, 2026
Karyopharm Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcriptbenzinga.com
Karyopharm Therapeutics (NASDAQ:KPTI) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you
Via Benzinga · August 13, 2026
Top movers in Friday's sessionchartmill.com
Via Chartmill · July 31, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · July 31, 2026
Gapping stocks in Friday's sessionchartmill.com
Via Chartmill · July 31, 2026
Friday's pre-market session: top gainers and loserschartmill.com
Via Chartmill · July 31, 2026
Thursday's after hours session: top gainers and loserschartmill.com
Via Chartmill · July 30, 2026
Which stocks are moving on Monday?chartmill.com
Via Chartmill · July 20, 2026
Karyopharm Therapeutics Spotlights Selinexor Milestones, ASCO Data and Cancer Trial Readoutsmarketbeat.com
Karyopharm Therapeutics (NASDAQ:KPTI) executives used an H.C. Wainwright BioConnect Conference appearance to highlight upcoming clinical and regulatory milestones for selinexor, the company’s oral nuclear export inhibitor marketed as XPOVIO in multiple myeloma.
Chief Executive Officer Richard Pauls
Via MarketBeat · May 26, 2026